DiaMedica Therapeutics Inc.
DMACBiotechnology
$9.52−3.05%As of Oct 29vs prior close
- Market cap
- $513.4M
- P/E (TTM)
- –
- From 52W high
- −3.05%
- EPS (LTM)
- -$0.72
- Revenue (YE18)
- $500K
- Dividend yield
- 0.00%
Nomior Score
46
Steady ProfileBottom 41% of the scored universe
Growth—
Quality36
Value53
Momentum58
Resilience45
Connections
Revenue to profitYE18
The operating loss was 1352% of revenue.
Who owns it
1fund